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Abstract
Background: Basidiomycete high-redox potential laccases (HRPLs) working in human physiological fluids
(pH 7.4, 150 mM NaCl) arise great interest in the engineering of 3D-nanobiodevices for biomedical uses. In two
previous reports, we described the directed evolution of a HRPL from basidiomycete PM1 strain CECT 2971: i) to be
expressed in an active, soluble and stable form in Saccharomyces cerevisiae, and ii) to be active in human blood. In
spite of the fact that S. cerevisiae is suited for the directed evolution of HRPLs, the secretion levels obtained in this
host are not high enough for further research and exploitation. Thus, the search for an alternative host to
over-express the evolved laccases is mandatory.
Results: A blood-active laccase (ChU-B mutant) fused to the native/evolved α-factor prepro-leader was cloned
under the control of two different promoters (PAOX1 and PGAP) and expressed in Pichia pastoris. The most active
construct, which contained the PAOX1 and the evolved prepro-leader, was fermented in a 42-L fed-batch bioreactor
yielding production levels of 43 mg/L. The recombinant laccase was purified to homogeneity and thoroughly
characterized. As happened in S. cerevisiae, the laccase produced by P. pastoris presented an extra N-terminal
extension (ETEAEF) generated by an alternative processing of the α-factor pro-leader at the Golgi compartment. The
laccase mutant secreted by P. pastoris showed the same improved properties acquired after several cycles of
directed evolution in S. cerevisiae for blood-tolerance: a characteristic pH-activity profile shifted to the neutral-basic
range and a greatly increased resistance against inhibition by halides. Slight biochemical differences between both
expression systems were found in glycosylation, thermostability and turnover numbers.
Conclusions: The tandem-yeast system based on S. cerevisiae to perform directed evolution and P. pastoris to
over-express the evolved laccases constitutes a promising approach for the in vitro evolution and production of
these enzymes towards different biocatalytic and bioelectrochemical applications.
Keywords: High-redox potential laccase, Functional expression, Pichia pastoris, Saccharomyces cerevisiae, Directed
evolution, Halide inhibition, Hydroxyl inhibition, Blood tolerance
Background
Laccases (benzenediol:oxygen oxidoreductase, E.C. 1.10.3.2.)
are extracellular, multicopper oxidases widely distributed in
fungi, higher plants, bacteria, lichens and insects [1-3]. They
contain a T1 copper atom at which the reducing substrate
is oxidized and a trinuclear copper cluster at which oxygen
is reduced to water [4]. Laccases are able to oxidize a broad
range of phenolic and non-phenolic compounds expanding
further its broad substrate specificity through the inclusion
of redox mediators from natural or artificial sources [5].
The physiological roles of laccases are diverse and depend
on their origin. In plants, these enzymes seem to be
involved in wound response, fruiting body formation,
cell-wall reconstitution and synthesis of lignin [6]. Role
attributes for bacterial laccases cover copper homeostasis,
morphogenesis and pigmentation of spores to confer resist-
ance to stress factors [2]. In fungi, laccases carry out a var-
iety of physiological roles including morphogenesis, fungal
plant-pathogen/host interaction and lignin mineralization
[1]. Among fungal laccases, those produced by the basidio-
mycete white-rot fungi are of great biotechnological interest
due to their higher redox potential at the T1 site [7]. Thus,
high-redox potential laccases (HRPLs) find applications in
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the production of second generation biofuels, pulp-kraft
biobleaching, bioremediation, organic syntheses and the
development of biosensors and miniature biofuel cells
for medical uses [8-10].
Over 20 fungal laccases have been heterologously
expressed in the yeasts Pichia pastoris and Saccharomyces
cerevisiae for different purposes [11,12]. In general terms,
both organisms are suitable for the expression of eukaryotic
genes. These hosts are easy to manipulate due to the avail-
ability of a large set of molecular biology tools; besides, they
have the ability to perform post-translational modifications
(disulfide bridge formation, C- and N-terminal processing,
glycosylation) readily secreting active enzymes to the
culture broth [13]. Particularly, S. cerevisiae arise a great
interest in synthetic biology and protein engineering by
directed evolution [14,15]. With a sophisticated eukaryotic
device supported by a high frequency of homologous DNA
recombination, the construction of complex metabolic
pathways by in vivo splicing expression cassettes and/or the
directed evolution of cumbersome systems (e.g. ligninolytic
enzyme consortiums) are simply performed [15,16]. Indeed,
the battery of reliable in vivo recombination methods
based on S. cerevisiae physiology make this budding
yeast a powerful cell factory for plenty of potential
applications [15]. Despite these advantages, the practical
use of S. cerevisiae in different industrial settings is
limited by its rather low secretion levels [11]. Although
the methylotrophic yeast P. pastoris is not the favorite host
for directed evolution experiments (the lack of episomal
vectors together with low transformation efficiencies
constrain the building of mutant libraries) [17], it does
show some attractive features which may complement
S. cerevisiae in the synthetic evolutionary scenario: spe-
cifically, the ability to grow at very high cell densities under
the control of strong promoters and secrete high amounts
of protein [18]. Even though the expression levels reported
for recombinant fungal laccases in these yeasts are diverse
(Table 1), overall they are much higher in P. pastoris,
ranging from 4.9 to 517 mg/L [19-25], than in S. cerevisiae,
where they vary from 2 to 18 mg/L [26-30].
In a previous work we tackled the directed evolution of
the HRPL from the white-rot fungus PM1 strain CECT
2971 to be secreted in S. cerevisiae (with levels of ~8 mg/L)
[28]. This evolved PM1 laccase was recently tailored to
be active in human blood (at pH 7.4 and high NaCl
concentration −150 mM-) [31]. HRPLs are strongly
inhibited by modest concentrations of OH- and Cl-,
which tightly bind to the catalytic copper centers
interrupting the catalysis. To surpass such inhibition,
several rounds of laboratory evolution in combination
with semi-rational approaches were carried out using a
screening assay based on the biochemical composition
of human blood. Here, we describe the cloning and
over-expression of this blood tolerant laccase in P. pastoris.
The recombinant enzyme was tested with different
promoters and fermentation conditions. The fermentation
of the best construct was scaled up in a 42L-bioreactor
to 20L fermentation volume, purified, and biochemically
characterized. Laccase properties were compared to
those obtained for the same mutant enzyme expressed
by S. cerevisiae.
Results and discussion
Heterologous functional expression of blood tolerant
laccases in P. pastoris
The departure point of the present study is a thermostable
laccase from basidiomycete PM1, which was first subjected
to 8 generations of in vitro evolution for functional expres-
sion in S. cerevisiae [28] and thereafter to 4 further cycles
of evolution to become active in human blood [31]. The
final variant of this process (ChU-B mutant) is formed by
the α-factor prepro-leader plus the mature laccase. The
ChU-B whole fusion gene harbours 22 mutations (8 silent).
Beneficial mutations enhancing functional expression or
activity are both located in the signal sequence (5 mutations)
and in the mature protein (7 mutations). Besides, the mature
protein presents two mutations, F396I and F454E, placed at
the second coordination sphere of the T1 Cu, which are re-
sponsible for the activity shown in human blood (Figure 1).
To test ChU-B expression levels in P. pastoris, four
different constructs were built, including native and
evolved α-factor prepro-leaders in combination with two
expression vectors: pPICZαA under the control of the
methanol inducible alcohol oxidase promoter (PAOX1)
Table 1 List of fungal laccases heterologously expressed
in P. pastoris and S. cerevisiae
Heterologous
host
Laccase source Expression
yields
(mg/L)
Promoter Reference
P. pastoris Botrytis acladaa 517 GAPc [19]
P. pastoris Botrytis acladaa 495 AOX1d [20]
P. pastoris Pleurotus sajor-cajub 4.9 AOX1d [21]
P. pastoris Pycnoporus
cinnabarinusb
8 AOX1d [22]
P. pastoris Trametes sp. 420b 136 AOX1d [23]
P. pastoris Trametes sp. AH28-2b 31.6 AOX1d [24]
P. pastoris Trametes trogii b 17 AOX1d [25]
S. cerevisiae Melanocarpus
albomycesa
7 GAL1d [26]
S. cerevisiae Myceliophthora
thermophilaa,*
18 ADH1c [27]
S. cerevisiae PM1b,* 8 GAL1d [28]
S. cerevisiae Pycnoporus
cinnabarinusb,*
2 GAL1d [29]
S. cerevisiae Trametes sp. C30b 2 GAL10d [30]
aAscomycete; bBasiodiomycete; cConstitutive promoter; dInducible promoter.
*Laccase functional expression achieved by directed evolution.
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and pGAPZαA under the control of the constitutive
glyceraldehyde 3-phosphate dehydrogenase promoter
(PGAP) (Figure 2). Transformed clones were pre-screened
for laccase expression on agar plates supplemented with
ABTS, resulting in all four cases in a green halo around the
colonies due to substrate oxidation by laccase. The appar-
ent most active clones were further subjected to microtiter
fermentations (in 96 deep-well plates). Of this set of experi-
ments, PAOX1 clones showed the highest ABTS-activity and
they were subjected to small scale fed-batch fermentation
Figure 1 Mutations in the ChU-B mutant fusion gene. The α-factor pre-leader is depicted in orange, the α-factor pro-leader in blue, and the
mature laccase in red. The 15 mutations accumulated in the directed evolution for functional expression in yeast are represented as yellow stars,
while the 7 mutations resulted from the evolutionary process for activity in blood are shown as white diamonds. Silent mutations are underlined.
Figure 2 Cloning strategy for the construction of pPICZαChU-B, pGAPZαChU-B, pPICZα*ChU-B and pGAPZα*ChU-B plasmids. The
pJRoC30α*ChU-B was used as template to amplify ChU-B with/without the evolved α-factor prepro-leader (α*) from S. cerevisiae. See
Methods section for details.
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(500 mL bioreactor, Figure 3A, B). Laccase activity was c.a.
1.7-fold higher for the construct containing the evolved
prepro-leader (i.e. 580 ABTS-U/L vs. 990 ABTS-U/L for
the laccase with the original and the mutated α-factor sig-
nal sequence, respectively). Accordingly, production of the
construct with the evolved prepro-leader was scaled up in a
20-L fermentation. The maximum volumetric activity
was reached after 151 h (3220 ABTS-U/L). Cultivation
was not stopped at this time since wet biomass was still in-
creasing and we could expect higher amounts of enzyme
to be secreted. Unfortunately, laccase activity dimin-
ished to 2830 ABTS-U/L at harvesting time (165 h), an
effect that may be ascribed to proteolytic degradation
by released intracellular proteases, Figure 3C [32].
Under these conditions, the final laccase production was
43 mg/L. This was 5.4-fold higher than that obtained in
shake-flask cultures of S. cerevisiae (8 mg/L); the latter can-
not yield the high cell density levels of P. pastoris [32],
which precludes its use in bioreactor [28]. Compared to
other basidiomycete laccases secreted by P. pastoris, the
ChU-B secretion was 9-, 5- and 2.5-fold higher than
those of laccases from Pleurotus sajor-caju, Pycnoporus
cinnabarinus and Trametes trogii, respectively, and
very similar to that of the Trametes sp. AH28-2 laccase.
The production yields achieved with the laccase from
Trametes sp. 420 and the ascomycete Botrytis aclada lac-
case were much higher (Table 1).
Biochemical characterization
Glycosylation and thermostability
The ChU-B laccase produced in P. pastoris was purified by
three chromatographic steps resulting in a homogeneous
sample, which was compared with the purified counterpart
from S. cerevisiae [31]. The molecular mass deduced from
SDS-PAGE was ~60 kDa for the enzyme secreted by
P. pastoris and S. cerevisiae, Figure 4A. The MALDI-TOF
(Matrix-Assisted Laser Desorption and Ionization-Time
Of Flight) mass spectrometry analysis allowed a more
accurate estimation of molecular masses (62541 Da and
60310 Da for the laccase from P. pastoris and S. cerevisiae,
respectively). From the molecular mass determined using
the amino acid composition (53939 Da), glycosylation pat-
terns of 16% and 12% for the laccase from P. pastoris and
S. cerevisiae were calculated (Table 2). Unlike S. cerevisiae,
whose tendency to add in high extent mannose moieties
at the Golgi compartment led to hyper-glycosylated
heterologous proteins, P. pastoris is known to introduce
outer sugar chains to a lesser extent (being more appropri-
ate than S. cerevisiae to produce, for example, proteins for
crystallization studies) [13]. These results address a longer
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Figure 3 Laccase expression in P. pastoris. (A and B) Fermentation in a 500-mL bioreactor of P. pastoris transformants expressing the ChU-B
mutant joined to the original (A) and the evolved (B) α-factor prepro-leader under the control of the PAOX1. After 22 h of batch phase, glycerol
feed was maintained for 5 hours and thereafter the methanol induction started. Methanol was pumped to the culture so that a DO level ~4%
was maintained throughout the fermentation. (C) 20-L fermentation in a 42-L bioreactor of a P. pastoris clone transformed with pPICZα*ChU-B.
Fermentation comprised four steps: batch phase for 22 h, glycerol phase for 5 h, transition phase for 5 h to adapt the culture to grow on
methanol, induction phase for 136 h. Black circles, laccase activity at the induction phase; black triangles, wet biomass; white squares, extracellular
protein concentration.
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residence time at the Golgi of ChU-B mutant in P. pastoris
than in S. cerevisiae. Comparing our data with other
HRPLs expressed in P. pastoris, the degree of glycosylation
is similar to that of the highly related T. trogii laccase
(97% of sequence identity with ChU-B [33]) but much lower
than that of the hyper-glycosylated P. cinnabarinus laccase
(with ~75% of sequence identity with ChU-B laccase),
which probably has to face several bottlenecks during
exocytosis (with glycosylation degrees of 36% and ~50%
in P. pastoris and S. cerevisiae, respectively [22,29]).
Kinetic thermostability was determined by measuring
the T50 (the temperature at which the enzyme retains
50% of its activity after ten minutes of incubation). In
spite of the fact that hyper-glycosylation is generally
reported to confer higher thermostability [34], the T50 of
the laccase variant produced in P. pastoris was ~6°C be-
hind its counterpart from S. cerevisiae, Table 2. Only
Figure 4 Biochemical characterization of ChU-B mutant. (A) SDS-PAGE: Lane 1, protein standards; lane 2, ChU-B from P. pastoris; lane 3,
ChU-B from S. cerevisiae. Samples were resolved on a 12% SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue. (B and C) pH
activity profiles. Black circles, ChU-B from P. pastoris; white circles, ChU-B from S. cerevisiae. Activities were measured in 100 mM Britton and
Robinson buffer in the pH range from 3.0 to 9.0 with 3 mM DMP (B) or 3 mM ABTS (C) as the reducing substrates. Relative activity (in %)
was calculated with respect to the activity at the optimum pH and each point, including the standard deviation, is the average of three
independent experiments.
Table 2 Biochemical characteristics of ChU-B mutant
produced in P. pastoris and S. cerevisiae
Feature ChU-B from
P. pastoris
ChU-B from
S. cerevisiae
Expression levels (mg/L) 43 8
MW1 53,939 53,939
MW2 62,541 60,310
Glycosylation (%) 16 12
N-terminal end ETEAEFSIGP ETEAEFSIGP
Optimum pH (with ABTS) 4 4
Optimum pH (with DMP) 5 5
T50 (°C) 57.9 63.7
1Calculated from the amino acid composition (http://web.expasy.org/compute_pi/).
2Determined by MALDI-TOF mass spectrometry. The extra N-terminal extension is
highlighted in bold.
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the careful examination of thermodynamic stability
could give us new clues about whether the laccase
overglycosylation in P. pastoris is affecting the protein
folding and stability.
N-terminal end
We recently reported an extra N-terminal extension of
six amino acids in our evolved laccase, as consequence
of an alternative processing at the Golgi compartment. It
was concluded that this extra tail was beneficial for
secretion without jeopardizing the biochemical laccase
properties [35]. In order to know whether similar processing
takes place in P. pastoris, ChU-B was subjected to end-
terminal sequencing. Indeed, the same N-terminal extension
ETEAEF was detected in the mature protein revealing the
lack of sufficient amount of STE13 protease in P. pastoris
for a correct cleavage of the α-factor pro-leader. Our results
are in good agreement with several studies in which
STE13 was not capable of processing the high levels of
α-factor prepro-leaders fusion genes, resulting in an extra
N-terminal tail linked to the mature protein [13,35,36].
Evolved properties of ChU-B laccase
pH activity profiles HRPLs are fully inactive at neutral
or basic pHs due to a reversible OH- inhibition
process. One of the most remarkable improvements of
ChU-B mutant after directed evolution was the shift in
the pH activity profile towards the neutral-alkaline side
(pH of human blood is around 7.4). ChU-B produced by S.
cerevisiae retained ~20% and ~10% of its initial activity at
physiological pH with DMP and ABTS as substrates, re-
spectively, whereas the activity of parent type (OB-1 mutant)
at this pH was negligible [31]. Almost identical pH activity
shapes (with the same optimal pH values at 5.0 for DMP
and 4.0 for ABTS) were detected with independency of the
producing yeast indicating that this important acquired
feature was also shown by the mutant expressed in P.
pastoris (Figure 4B, C). Even though the pH profile was
shifted (including a change in the optimum pH for DMP
from 4.0 to 5.0), as occurs for the rest of fungal laccases a
bell shaped profile was observed for the phenolic substrate
DMP, which is the result of two opposite effects: (i) activa-
tion in the acidic range due to higher redox potential
difference between the phenol and the T1 Cu (the redox
potential of phenols decreases when pH increases while the
redox potential of the laccase hardly varies) and (ii) inacti-
vation at alkaline pH due to the accumulation of OH-,
which bind to the T2 site interrupting the internal electron
transfer from the T1 to the T2/T3 centers [37]. Concerning
the non-phenolic substrate ABTS, the pH activity profile
showed the expected monotonic shape as the oxidation of
this compound does not include proton exchange and the
only effect involved is the inhibition by OH-.
Inhibition by halides HRPLs are strongly inhibited
by the presence of modest concentrations of halides
(Cl-, Br-, F- but not I-) [38]. Therefore, the use of HRPLs in
miniature biofuel cells operative in mammal physiological
fluids (with ~150 mM NaCl) is limited, on the one hand by
the negligible activity at neutral-alkaline pH, and on the
other, by the low laccase tolerance against Cl-. The
ChU-B mutant greatly surpassed the halide inhibition
by directed evolution and this important property was
checked in the variant expressed by P. pastoris. The I50
values (the concentration of halide at which the enzyme
keeps 50% of its initial activity) were determined at acidic
and physiological pH using ABTS and DMP as substrates.
Whilst the I50Cl
- of parent type (the OB-1 mutant) was
176 mM and 208 mM for ABTS and DMP at acidic pH,
respectively, these values were risen up in the ChU-B
variant from S. cerevisiae to 1025 mM and 818 mM for
these substrates. Additionally, a slight increase in the I50F
-
value for both substrates at acidic pH was also observed
(parent type: 70 μM and 167 μM for ABTS and DMP,
respectively; ChU-B mutant from S. cerevisiae: 109 μM and
183 μM for ABTS and DMP, respectively) [31]. These
improved I50F
- and I50Cl
- were maintained in the
mutant expressed in P. pastoris being similar in both
yeasts (i.e. I50Cl
- ~1000 mM and I50F
- above 100 μM both
for ABTS and DMP at acidic pH), Table 3, Figure 5A, B.
Since the smaller the ionic diameter of the halide the easier
the access to the T2/T3 trinuclear copper cluster [39], an
inhibition potency F->Cl- was observed with independence
of the substrate tested, Table 3, Figure 5A, B. When halide
inhibition was measured at physiological pH, the enzyme
expressed in both yeasts showed I50F
- which rose from
the μM range at acid pH to the mM range at blood pH,
Figure 5A. Moreover, laccase activity was not affected
by increasing concentrations of Cl- (Figure 5C). This
data is consistent with the described effect by which the
halide inhibition of laccase activity is weaker at alkaline
pH values. Under such conditions, the presence of a
deprotonated water molecule coordinating the T2 Cu
Table 3 I50 values (in mM) of sodium halides for ChU-B
mutant produced in P. pastoris and S. cerevisiae
Inhibitor Substrate pH ChU-B from
P. pastoris
I50 (mM)
ChU-B from
S. cerevisiae
I50 (mM)
NaF ABTS 4.0 0.134 0.109
ABTS 7.4 (blood buffer) 40 42
DMP 5.0 0.174 0.183
NaCl ABTS 4.0 1106 1025
ABTS 7.4 n.m. n.m.
DMP 5.0 931 818
n.m. non-measurable. Inhibition studies were performed at the optimum pH
activity value for each substrate tested (4.0 and 5.0 for ABTS and DMP,
respectively) and at physiological pH (7.4) with ABTS as reducing substrate.
Mate et al. BMC Biotechnology 2013, 13:38 Page 6 of 12
http://www.biomedcentral.com/1472-6750/13/38
results in a competition with the halide for binding
to the T2 site [37,40,41].
Kinetics
Kinetics parameters were measured for phenolic and
non-phenolic substrates at optimum and physiological
pH (Table 4). The Km for ABTS and DMP was similar for
the laccase produced either by S. cerevisiae or P. pastoris.
By contrast, the kcat values for the two substrates
were around 2.7 and 4.8-fold higher for the laccase from
S. cerevisiae than those of the laccase from P. pastoris.
Possibly, the detected glycosylation differences between
both laccases are in part responsible for this effect. Further
crystallization studies along with computational analysis
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Figure 5 Inhibition of ChU-B by halides. (A) NaF inhibition with (i) ABTS at pH 4.0 (X-axis in μM; black circles, ChU-B from P. pastoris; white
circles, ChU-B from S. cerevisiae); (ii) DMP at pH 5.0 (X-axis in mM; black squares, ChU-B from P. pastoris; white squares, ChU-B from S. cerevisiae;
(iii) ABTS at pH 7.4 (X-axis in mM; black diamonds, ChU-B from P. pastoris; white diamonds, ChU-B from S. cerevisiae). (B) NaCl inhibition with
(i) ABTS at pH 4.0 (black circles, ChU-B from P. pastoris; white circles, ChU-B from S. cerevisiae); (ii) DMP at pH 5.0 (black squares, ChU-B from
P. pastoris; white squares, ChU-B from S. cerevisiae). (C) NaCl inhibition at physiological pH (7.4) with ABTS as substrate (black bars, ChU-B from
P. pastoris; grey bars, ChU-B from S. cerevisiae).
Table 4 Steady-state kinetic parameters of ChU-B mutant expressed in P. pastoris and S. cerevisiae
Substrate pH ChU-B from P. pastoris ChU-B from S. cerevisiae (Parental type, OB-1mutanta)
Km (mM) kcat (s
-1) kcat/Km
(mM-1s-1)
Km (mM) kcat (s
-1) kcat/Km
(mM-1s-1)
Km (mM) kcat (s
-1) kcat/Km
(mM-1s-1)
ABTS 3.0 0.024 ± 0.002 22.3 ± 0.5 929 0.023 ± 0.001 57.0 ± 0.9 2478 0.0063 ± 0.0009 200 ± 7 31746
7.4 0.26 ± 0.01 1.13 ± 0.02 4.35 0.32 ± 0.02 3.09 ± 0.07 9.66 n.d. n.d. n.d.
DMP 5.0 1.91 ± 0.05 5.65 ± 0.05 2.96 2.0 ± 0.2 19.5 ± 0.5 9.75 0.14 ± 0.02 134 ± 5 957
7.4 0.23 ± 0.03 0.41 ± 0.02 1.78 0.22 ± 0.03 1.95 ± 0.05 8.86 n.d. n.d. n.d.
a Data from Maté et al., 2010. n.d. not determined.
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would be important to clarify the differences in kcat values
and thermostabilities [42]. When comparing kinetics with
the original parent type expressed in S. cerevisiae [28], the
Km at acidic pH was increased around 4- and 14-fold
whereas the kcat was ~3.5- and 7-fold lower than those
of the parental type, for ABTS and DMP respectively.
Mutations F396I and F454E, both located at the second
coordination sphere of the T1 Cu, enabled the enzyme to
be active under physiological conditions albeit at the cost
of catalytic efficiency (Figure 6). The activity of ChU-B
from P. pastoris in physiological fluids was determined by
measuring the oxygen consumption in human plasma and
blood. Comparable responses for both human fluids were
obtained (31 ± 7 and 27 ± 1 min-1 for blood and plasma,
respectively). Since for the application of this enzyme in
3D-nanodevices working in physiological conditions, the
laccase is directly connected to the cathode of a biofuel cell,
the reducing substrates are replaced by a direct electronic
current from the anode, which is the rate limiting step in
the catalytic mechanism. In fact, ChU-B is functional
in blood because of the slowed down kinetics. As we
have recently reported, the modification of the second
coordination sphere of the T1 Cu comes at the cost of
reducing the activity at acidic values, which simultaneously
compensates for T2 Cu inhibition activating ChU-B in the
presence of halides and OH- [31].
Conclusions
The blood tolerant laccase engineered by laboratory
evolution in S. cerevisiae is easily secreted in P. pastoris
with higher production yields whilst maintaining its evolved
properties in terms of halide tolerance and pH activity
profiles. These results support the use of S. cerevisiae as the
preferred host to evolve ligninolytic enzymes and P. pastoris
to over-express them for different purposes. Indeed, the
application of this tandem-yeast evolution/expression
system can be extended from laccases to other ligninolytic
oxidoreductases (lignin-, manganese- and versatile-
peroxidases, aromatic peroxygenases, aryl alcohol oxidases)
whose engineering for challenging biocatalytic applications
are currently pursued by many research groups.
Methods
Strains and chemicals
The P. pastoris expression vectors pPICZαA and pGAPZαA,
the Escherichia coli strain DH5α, the P. pastoris strain X-33
and the antibiotic Zeocin were purchased from Invitrogen
(Carlsbad, CA, USA). Restriction endonucleases, the Rapid
DNA Ligation Kit, containing T4 DNA ligase, and the
shrimp alkaline phosphatase were obtained from Fermentas
(Burlington, Canada). Nucleic acid amplifications were done
employing Phusion High-Fidelity DNA Polymerase from
New England Biolabs (Beverly, USA), dNTP mixture from
Thermo Fisher Scientific (Waltham, MA, USA) and oligo-
nucleotide primers from VBC Biotech (Vienna, Austria).
The Illustra GFX PCR DNA and gel band purification kit
was obtained from GE Healthcare (Buckinghamshire, UK).
All chemicals and media components were of the highest
purity available.
Laccase functional expression in P. pastoris
Laccase constructs for P. pastoris
A 1.5-kDa DNA fragment containing the coding region
of the ChU-B mutant laccase gene was cloned with the
BA
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Figure 6 Location of the two mutations responsible for blood tolerance in the ChU-B mutant (B) compared with the corresponding
residues in the parental type OB-1 (A). The F396I and F454E mutations are shown in yellow sticks and copper ions are depicted as blue
spheres. The three residues in charge of the internal electron transfer from T1 Cu to T2/T3 cluster are displayed as magenta sticks. Residues
involved in the first coordination sphere of the catalytic coppers and their interactions (green dashes) are also represented. The 3D-structure
model is based on the crystal structure of the Trametes trogii laccase (97% identity, PDB: 2HRG) [33].
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original and the mutated α-factor prepro-leader from S.
cerevisiae into the expression vectors pPICZαA and
pGAPZαA. The vector pJRoC30α*ChU-B, resulting from
a previous directed evolution experiment [31], was used
to amplify the laccase gene without the evolved α-factor
signal peptide with the primers 5PM1EcoR1 (5’-AAGAA
TTCAGCATTGGGCCAGTCGCAG-3’) and 3PM1Xba1
(5´-AGGTCTAGATTACTGGTCGTCAGGCGAG-3´),
which included targets for EcoRI and XbaI restriction
enzymes, respectively (in bold). The laccase gene fused to
the evolved α-factor signal sequence was amplified using
the primers 5ALPHABst1 (5´-ATTTCGAAACGATGAGA
TTTCCTTCAATTTTTACTGC-3´), which included the
BstBI target (in bold), and 3PM1Xba1. PCR reactions
were performed using a GeneAmp PCR System 2700
thermocycler (Applied Biosystems, Foster City, CA, USA)
in a final volume of 25 μL containing 0.6 μM of each
primer, 2 ng template, 800 μM dNTPs (200 μM each), 3%
dimethyl sulfoxide (DMSO), 1.5 mM MgCl2 and 0.5 U of
Phusion polymerase. The PCR conditions were 98°C for 30
sec (1 cycle); 98°C for 10 sec, 62°C for 20 sec, 72°C for 45
sec (30 cycles); and 72°C for 7 min (1 cycle). The PCR
products were purified using the Illustra GFX PCR DNA
and gel band purification kit and then digested with the re-
striction enzymes BstBI and XbaI -in the case of the fusion
gene- or EcoRI and XbaI -in the case of the gene encoding
the mature protein- at 37°C for 3 h. The pPICZαA and
pGAPZαA vectors were equally treated and then their 5’
and 3’ ends were dephosphorylated using shrimp alkaline
phosphatase at 37°C for 1 h. The PCR product and the
linearized vector were ligated with T4 DNA ligase at
room temperature for 30 min. After transformation of the
constructs into chemically competent E. coli DH5α cells,
the plasmids were proliferated, linearized with the restric-
tion enzyme SacI at 37°C for 1 h and transformed into
electro-competent P. pastoris X-33 cells. Electro-competent
Pichia cells were prepared and transformed following
the condensed protocol of Lin-Cereghino et al. [43].
Transformants were grown on YPD plates (10 g/L yeast
extract, 20 g/L peptone, 4 g/L glucose and 15 g/L agar)
containing 25 mg/L zeocin and screened on indicator agar
plates with BMM agar (100 mM potassium phosphate
buffer pH 6.0, 3.5 g/L yeast nitrogen base without amino
acids nor ammonium sulfate, 10 g/L ammonium sulfate,
400 μg/L biotin, 0.5% methanol, 20 g/L agar) containing
0.2 mM ABTS and 0.1 mM CuSO4.
Small scale fed-batch fermentation
P. pastoris clone harbouring the ChU-B mutant with the
original (α) and/or the mutated (α*) -factor signal peptide
under control of the AOX1 promoter was cultivated in a
500-mL Multifors bioreactor (Infors HT, Bottmingen, CH)
with a starting volume of 300 mL basal salts medium
(26.7 mL/L 85% phosphoric acid, 0.93 g/L CaSO4·2H2O,
14.9 g/L MgSO4·7H2O, 18.2 g/L K2SO4, 4.13 g/L
KOH; 40 g/L glycerol). After sterilization, the medium
was supplemented with 4.35 mL/L PTM1 trace salts
(as described by Invitrogen), 100 μL Antifoam 204
(Sigma, St. Louis, MO, USA) and 0.1 mM CuSO4. The pH
of the medium was adjusted to pH 5.0 with 28% ammo-
nium hydroxide and maintained at this value throughout
the whole fermentation process. The fermentations
were started by adding 25 mL of preculture grown on
YPD medium in 250-mL baffled shake flasks at 125 rpm
and 30°C overnight. The cultivations were performed
according to the Pichia Fermentation Process Guidelines of
Invitrogen with some modifications. The batch was run at
30°C, 500 rpm and an air flow of 0.2 L/min. After depletion
of the glycerol in the batch medium, the fed-batch phase
was started with a feed of 50% (w/v) glycerol containing 12
mL/L PTM1 trace salts for 5 h to increase the cell biomass
under limiting conditions. For induction, the temperature
was reduced to 25°C and the feed was switched to 100%
methanol with 12 mL/L PTM1 trace salts at an initial feed
rate of 0.6 mL/h until the culture was fully adapted to
methanol. Subsequently the feed rate was adjusted to keep
the oxygen saturation constant at 4% at a constant air sup-
ply of 2 L/min and a stirrer speed of 800 rpm. Samples
were taken regularly and clarified by centrifugation. The
wet biomass was measured by weighing centrifuged tubes
containing culture samples after removing the supernatant.
The soluble protein concentration was quantified using
the Bio-Rad Protein Assay (Bio-Rad, CA, USA), with
bovine serum albumin as standard. The volumetric ac-
tivity was assayed spectrophotometrically using ABTS
(εABTS•+, 418nm=36,000 M
-1 cm-1) as substrate. The reaction
was followed for 5 min at room temperature in a Lambda
35 UV/Vis spectrophotometer (Perkin Elmer). The ABTS-
based assay contained 3 mM ABTS final concentration in
100 mM sodium acetate buffer pH 4.0.
Large scale fed-batch fermentation
The α*-ChU-B mutant under control of the AOX1 pro-
moter (pPICZα*ChU-B construct) was large-scale produced
in P. pastoris using a 42-L autoclavable stainless steel
bioreactor (Applikon Biotechnology, Schiedam, The
Netherlands) filled with 10 L of basal salts medium.
After sterilization, 4.35 mL/L PTM1 trace salts and 2 mL
Antifoam 204 were added to the medium. Furthermore,
the pH was set to pH 5.0 with 28% ammonium hydroxide,
keeping it at this value throughout the entire process. The
fermentation was started by adding 1 L of P. pastoris
preculture grown on YPD medium in several 1-L baffled
shake flasks at 200 rpm and 30°C overnight. According to
the Pichia Fermentation Process Guidelines aforementioned,
the batch was run at 30°C and 600 rpm, keeping the
dissolved oxygen (DO) concentration above 4%. Once all
the glycerol was consumed from the batch growth phase,
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the glycerol fed phase was started with a feed of 50% (w/v)
glycerol containing 12mL/L PTM1 trace salts for 5 h to
increase the biomass. Afterwards, 0.5% (v/v) methanol
with 12 mL/L PTM1 trace salts and 0.1 mM CuSO4
were injected aseptically into the fermenter. From this
time on, the temperature was set to 25°C and the stirrer
speed to 750 rpm. After 5 h of transition phase, the feed
was switched to 100% methanol containing 12 mL/L
PTM1 trace salts and it was regulated to keep the DO
concentration between 1 and 3%. Samples were taken
regularly and wet biomass, protein concentration and
laccase activity were determined as mentioned above.
Purification of the laccase produced in P. pastoris
The culture broth of ChU-B mutant containing the
P. pastoris cells was clarified by centrifugation at 6000
rpm for 20 min at 4°C (Sorvall Evolution RC Superspeed
Centrifuge, Thermo Fisher Scientific) and solid ammo-
nium sulphate was slowly added to the supernatant to
30% saturation at 4°C. The suspension was centrifuged at
6000 rpm for 30 min at 4°C to discard the precipitated
protein (without laccase activity). Then, the supernatant-
containing laccase activity was applied to a 750-mL PHE
sepharose 6 FF column (chromatographic equipment and
materials from GE Healthcare) equilibrated with 50 mM
sodium acetate buffer pH 5.0 containing 30% saturation
ammonium sulphate. Proteins were eluted within a linear
gradient from 30 to 0% ammonium sulphate at a flow rate
of 20 L/min for 2 h. Fractions with laccase activity were
pooled, dialyzed and concentrated in 20 mM Bis-Tris HCl
buffer pH 6.5 (buffer A) using a hollow fiber cross-flow
module (Microza UF module SLP-1053, 10 kDa cut-off,
Pall Corporation, Port Washington, NY, USA). The sam-
ple was loaded onto a 19-mL Mono Q column, previously
equilibrated with buffer A. Proteins were eluted with a
linear gradient from 0 to 0.4 M of NaCl at a flow rate
of 2 mL/min for 1 h. Active fractions were pooled and
applied to a 70 mL PHE source column. Laccase was
eluted with a linear gradient from 15 to 0% ammonium
sulphate at a flow rate of 1 mL/min for 6 h. The fractions
with laccase activity were pooled, dialyzed against buffer
A, concentrated and stored at 4°C.
Production and purification of the laccase expressed in
S. cerevisiae
The ChU-B mutant was expressed in the protease deficient
Saccharomyces cerevisiae strain BJ5465 (LGC Promochem,
Barcelona, Spain) and purified to homogeneity following
the protocol reported in a former work [28].
Kinetic thermostability (T50 determination)
The thermostability of the different laccase samples was
estimated by assessing their T50 values using 96/384 well
gradient thermocyclers. Appropriate laccase dilutions were
prepared, such that 20 μL aliquots produced a linear
response in the kinetic mode. Subsequently, 50 μL samples
were assessed at each point in the gradient scale and a
temperature gradient profile ranging from 35 to 90°C was
established as follows (in °C): 35.0, 36.7, 39.8, 44.2, 50.2,
54.9, 58.0, 60.0, 61.1, 63.0, 65.6, 69.2, 72.1, 73.9, 75.0, 76.2,
78.0, 80.7, 84.3, 87.1, 89.0 and 90.0. After 10 min of
incubation, the samples were chilled on ice for 10 min
and further incubated at room temperature for 5 min. Next,
20 μL of samples were subjected to the same ABTS-based
colorimetric assay described above. Thermostability values
were deduced from the ratio between the residual activities
incubated at different temperature points and the initial
activity at room temperature.
pH activity profiles
Appropriate laccase dilutions were prepared in such a way
that 10 μL aliquots produced a linear response in the
kinetic mode. Plates containing 10 μL of laccase samples
and 180 μl of 100 mM Britton and Robinson buffer were
prepared at pH values of 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0 and
9.0. The assay commenced when 10 μL of 60 mM ABTS or
DMP was added to each well to give a final substrate con-
centration of 3 mM. The activities were measured in tripli-
cate in kinetic mode and the relative activity (in %) is based
on the maximum activity for each variant in the assay.
Halide inhibition (I50 determination)
The inhibitory effect of fluoride and chloride was measured
using two laccase substrates (ABTS and DMP) at their
corresponding optimal pH activity values (in 100 mM
sodium acetate buffer (pH 4.0) for ABTS and 100 mM
sodium tartrate buffer (pH 5.0) for DMP, as well as at
physiological pH (in 100 mM sodium phosphate buffer,
pH 7.4). Inhibition was determined by the I50 value
(the halide concentration at which only 50% of the initial
laccase activity is retained), as the complexity of the plots
complicated the extraction of the inhibition constant (Ki).
The assay mixture contained 2.4 mM ABTS or DMP, halide
(concentrations ranging from 0 to 1100 mM) and purified
laccase (0.2 and 1.7 nM for ABTS and DMP, respectively).
Each data point represents the mean value determined in at
least three independent experiments.
Kinetics parameters
As previously reported [28], steady-state enzyme kinetics
were determined using the following extinction coefficients:
ABTS, ε418 = 36000 M
-1 cm-1; DMP, ε469 = 27500 M
-1 cm-1
(relative to substrate concentration). To calculate the values
of Km and kcat, the average vmax was represented versus
substrate concentration and fitted to a single rectangular
hyperbola function in SigmaPlot 10.0, where parameter
a equales kcat and parameter b equals Km.
Mate et al. BMC Biotechnology 2013, 13:38 Page 10 of 12
http://www.biomedcentral.com/1472-6750/13/38
Determination of laccase activity in human plasma
and blood
Human blood was collected in BD VacutainerW blood
collection tubes (Plymoth, UK). Blood samples were
centrifuged for 10 min at 3000 rpm to obtain human
plasma, discarding the pellet after having extracted the
supernatant. Both plasma and blood were supplemented
with 10 mM ascorbic acid as laccase substrate and the
pH adjusted to 7.4. The activity of the ChU-B mutant in
both physiological fluids was determined by measuring
oxygen consumption in solution with a Clark electrode.
These experiments were performed using the Oxygraph
system (Hansatech Instruments, King´s Lynn, UK).
MALDI-TOF analysis
Matrix Assisted Laser Desorption and Ionization-Time Of
Flight (MALDI-TOF) experiments were performed on
an Autoflex III MALDI-TOF-TOF instrument (Bruker
Daltonics, Bremen, Germany) with a smartbeam laser. The
spectra were acquired at a laser power just above the
ionization threshold, and the samples were analysed in the
positive ion detection and delayed extraction linear mode.
Typically, 1000 laser shots were summed into a single mass
spectrum. External calibration was performed, using BSA
from Bruker, over a range of 30000–70000 Da. The 2,5-
dihydroxy-acetophenone (2,5-DHAP) matrix solution was
prepared by dissolving 7.6 mg (50 μmol) in 375 μL ethanol,
to which 125 μL of 80 mM diammonium hydrogen citrate
aqueous solution was added. For sample preparation,
2.0 μL of purified enzyme was diluted with 2.0 μL of
2% trifluoro acetic acid aqueous solution and 2.0 μL of
matrix solution. A volume of 1.0 μL of this mixture
was spotted onto the stainless steel target and allowed
to dry at room temperature.
N-terminal analysis
Purified laccases were resolved by SDS-PAGE and the
proteins transferred to polyvinylidene difluoride (PVDF)
membranes. The PVDF membranes were stained with
Coomassie Brilliant Blue R-250, after which the enzyme
bands were cut out and processed for N-terminal amino
acid sequencing on a precise sequencer at the Core
facilities of the Helmholtz Centre for Infection Research
(HZI; Braunschweig, Germany).
Protein modeling
The 3D-structure models of the PM1 mutant laccases
are based on the crystal structure of the Trametes trogii
laccase (PDB: 2HRG, 97% sequence identity with the
PM1 laccase) [33]. The protein models were generated
and analyzed as formerly reported [28].
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